Capital Impact Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Capital Impact Advisors’s Portfolio APLS Stock Details APLS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$508K	Sell
2023 Q1	$919K	Sell
2022 Q4	$722K	Hold
2022 Q3	$604K	Buy
2022 Q2	$601K	Buy